Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Healthcare Industry News PainChek (ASX: PCK) stock climbs on FDA approval — is this the breakout investors expected? PainChek Ltd (ASX: PCK) gains FDA De Novo clearance for its AI pain-assessment app, sparking a stock rally and opening a US $100 million market in US aged care. bySrinathOctober 8, 2025